Explore the full record of transactions filed by 左从林, Director. Director active across 1 company, notably 昭衍新药. Cumulatively, 44 filings have been logged. Activity tracked since 30 September 2025. The latest transaction was disclosed on 30 September 2025 (Sale). Regulator: AMF. All data is accessible without signup.
Declarations 44 total
● 董事,高级管理人员 · Executives · 30 Sept 2025 · 昭衍新药 20,000 shares A股 SSE:173000009615288770 ● 董事 · Executives · 13 Nov 2023 · 昭衍新药 4,000 shares A股 SSE:173000007087307460 ● 董事 · Executives · 8 Nov 2023 · 昭衍新药 3,000 shares A股 SSE:173000007075373760 ● 董事 · Executives · 6 Nov 2023 · 昭衍新药 199,960 shares A股 SSE:173000007068789150 ● 董事 · Executives · 3 Nov 2023 · 昭衍新药 148,000 shares A股 SSE:173000007065879970 ● 董事 · Executives · 3 Nov 2023 · 昭衍新药 489,940 shares A股 SSE:173000007065879800 ● 董事 · Executives · 2 Nov 2023 · 昭衍新药 1,000,000 shares A股 SSE:173000007060665860 ● 董事 · Executives · 27 Jun 2023 · 昭衍新药 300,000 shares A股 SSE:173000006685315140 ● 董事 · Executives · 26 Jun 2023 · 昭衍新药 200,000 shares A股 SSE:173000006682445340 ● 董事 · Executives · 16 Jun 2023 · 昭衍新药 300,000 shares A股 SSE:173000006666870560 ● 董事 · Executives · 12 Jun 2023 · 昭衍新药 196,300 shares A股 SSE:173000006654602560 ● 董事 · Executives · 27 Sept 2022 · 昭衍新药 3,025,954 shares A股 SSE:173000005913389900 ● 董事 · Executives · 6 Sept 2022 · 昭衍新药 2,141,980 shares A股 SSE:173000005894076400 ● 副总裁 · Executives · 4 Jul 2022 · 昭衍新药 10,584 shares A股 SSE:173000005746690560 ● 董事 · Executives · 1 Jul 2022 · 昭衍新药 2,000 shares A股 SSE:173000005648954080 ● 董事 · Executives · 23 Jun 2022 · 昭衍新药 4,775,000 shares A股 SSE:173000005614953250 ● 董事 · Executives · 16 Jun 2022 · 昭衍新药 1,000 shares A股 SSE:173000005599083140 ● 董事 · Executives · 7 Jun 2022 · 昭衍新药 1,000 shares A股 SSE:173000005576250560 ● 董事 · Executives · 26 May 2022 · 昭衍新药 320,000 shares A股 SSE:173000005552153250 ● 董事 · Executives · 24 May 2022 · 昭衍新药 460,400 shares A股 SSE:173000005547691360 ● 董事 · Executives · 23 May 2022 · 昭衍新药 456,370 shares A股 SSE:173000005545269540 ● 董事 · Executives · 20 May 2022 · 昭衍新药 286,160 shares A股 SSE:173000005542844740 ● 董事长 · Executives · 11 May 2022 · 昭衍新药 300,000 shares A股 SSE:173000005552088300 ● 董事 · Executives · 16 Dec 2021 · 昭衍新药 192,700 shares A股 SSE:173000005176769470 ● 董事 · Executives · 29 Sept 2021 · 昭衍新药 246,100 shares A股 SSE:173000004928451940 25 of 44 declarations
Load more (19 remaining) About 左从林 Zuo Conglin is a board member at Zhaoyan Pharmaceutical. In this role, he participates in strategic decision-making and oversees the company's operations. His experience in the pharmaceutical sector is a major asset for Zhaoyan Pharmaceutical.